We are live on ! Find out more
GLG Partners

GLG Partners Portfolio holdings

AUM $2.14B Turnover 59.22%
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JMEI
226
DELISTED
Jumei International Holding
JMEI
$1.06M 0.05%
36,239
-406
-1% -$11.9K
2016 Q1
7 quarters
WFC icon
227
Wells Fargo
WFC
$256B
$1.05M 0.05%
+17,269
New +$975K
2017 Q4
0 quarters
CHD icon
228
Church & Dwight
CHD
$27.1B
$1.04M 0.05%
+20,788
New +$975K
2017 Q4
0 quarters
BIIB icon
229
Biogen
BIIB
$37.6B
$1.04M 0.05%
3,268
-732
-18% -$235K
2017 Q3
1 quarter
HAL icon
230
Halliburton
HAL
$27.4B
$1.02M 0.05%
20,900
-97,880
-82% -$4.31M
2014 Q1
15 quarters
DOV icon
231
Dover
DOV
$27.7B
$1.01M 0.05%
12,352
+8,831
+251% +$684K
2017 Q3
1 quarter
UNVR
232
DELISTED
Univar Solutions
UNVR
$1M 0.05%
32,300
+27,823
+621% +$828K
2017 Q3
1 quarter
GM icon
233
General Motors
GM
$71.1B
$998K 0.05%
+24,343
New +$1.06M
2017 Q4
0 quarters
PH icon
234
Parker-Hannifin
PH
$119B
$996K 0.05%
+4,989
New +$928K
2017 Q4
0 quarters
ES icon
235
Eversource Energy
ES
$27.1B
$972K 0.05%
+15,381
New +$972K
2017 Q4
0 quarters
CELG
236
DELISTED
Celgene
CELG
$970K 0.05%
9,290
-6,321
-40% -$713K
2014 Q2
14 quarters
LDOS icon
237
Leidos
LDOS
$16B
$966K 0.05%
+14,967
New +$938K
2017 Q4
0 quarters
TDC icon
238
Teradata
TDC
$3.23B
$959K 0.04%
+24,947
New +$892K
2017 Q4
0 quarters
EXR icon
239
Extra Space Storage
EXR
$33.1B
$958K 0.04%
+10,958
New +$924K
2017 Q4
0 quarters
CME icon
240
CME Group
CME
$114B
$949K 0.04%
6,500
-7,000
-52% -$997K
2016 Q2
6 quarters
CNH icon
241
CNH Industrial
CNH
$18.7B
$929K 0.04%
+79,653
New +$881K
2017 Q4
0 quarters
KR icon
242
Kroger
KR
$41.6B
$924K 0.04%
+33,678
New +$784K
2017 Q4
0 quarters
PG icon
243
Procter & Gamble
PG
$400B
$913K 0.04%
+9,934
New +$893K
2017 Q4
0 quarters
GLNG icon
244
Golar LNG
GLNG
$4.34B
$895K 0.04%
+30,018
New +$722K
2017 Q4
0 quarters
DUK icon
245
Duke Energy
DUK
$101B
$879K 0.04%
+10,447
New +$913K
2017 Q4
0 quarters
ECHO icon
246
DELISTED
Echo Global Logistics
ECHO
$876K 0.04%
31,300
+13,400
+75% +$321K
2017 Q3
1 quarter
PPL icon
247
PPL
PPL
$26.9B
$843K 0.04%
+27,229
New +$978K
2017 Q4
0 quarters
GILD icon
248
Gilead Sciences
GILD
$210B
$834K 0.04%
+11,646
New +$884K
2017 Q4
0 quarters
SF icon
249
Stifel
SF
$10.8B
$807K 0.04%
+30,490
New +$746K
2017 Q4
0 quarters
MDLZ icon
250
Mondelez International
MDLZ
$85.7B
$753K 0.04%
17,591
+17,094
+3,439% +$718K
2017 Q1
3 quarters

Similar funds

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo, cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.